Clinical Trials Directory

Trials / Completed

CompletedNCT04635033

Intermittent Hypoxia Intervention in MS Patients

Safety and Tolerance of an Intermittent Intervention in MS Patients

Status
Completed
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
Universitätsklinikum Hamburg-Eppendorf · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This observational cohort study investigates the safety and feasibility of an intermittent hypoxia intervention in multiple sclerosis.

Conditions

Timeline

Start date
2018-09-19
Primary completion
2019-10-10
Completion
2019-10-10
First posted
2020-11-18
Last updated
2020-11-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04635033. Inclusion in this directory is not an endorsement.